NCT00342056View on ClinicalTrials.gov

Role of Gene Variation in Effectiveness of Gleevec Treatment

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

October 31, 2008

Conditions
CancerBreast Cancer
Trial Locations (2)

20010

Washington Hospital Center, Washington D.C.

Unknown

Katholieke Universiteit Leuven, U Hospitals UZ Gasthuisberg, Leuven

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00342056 - Role of Gene Variation in Effectiveness of Gleevec Treatment | Biotech Hunter | Biotech Hunter